Diagnostic Imaging Market Size, Share and Growth Outlook, 2026

Diagnostic Imaging Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Diagnostic Imaging Market size is forecast to increase from $31.7 Billion in 2026 to $48.28 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

The Diagnostic Imaging market report provides detailed analysis and outlook of Diagnostic Imaging segments including By Modality: (X-Ray Systems, Computed Tomography, Magnetic Resonance Imaging, Ultrasound Systems, Nuclear Imaging, Mammography Systems, Fluoroscopy Systems), By Application: (Cardiovascular, Oncology, Neurology, Musculoskeletal, Gastroenterology, Obstetrics), By End-User: (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Academic & Research Institutes, Physician Offices & Outpatient Clinics) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Diagnostic Imaging Industry Overview

The diagnostic imaging industry is undergoing a significant transformation driven by advancements in artificial intelligence, cloud-based imaging platforms, patient-centered imaging environments, and next-generation scanning technologies. Healthcare providers are increasingly investing in advanced diagnostic imaging systems that improve image quality, enhance workflow efficiency, support earlier disease detection, and deliver more personalized patient experiences. The growing integration of AI-powered image analysis, spectral imaging, enterprise imaging platforms, and digital radiology solutions is reshaping the way clinicians diagnose and manage complex diseases across oncology, cardiology, neurology, pediatrics, and preventive healthcare. As hospitals and imaging centers prioritize operational efficiency and precision diagnostics, the diagnostic imaging market continues to evolve toward highly connected, intelligent, and data-driven imaging ecosystems.

Patient-Centered Imaging Solutions Enhancing Pediatric Diagnostic Imaging

A major trend shaping the diagnostic imaging industry is the growing focus on improving patient comfort and reducing procedure-related anxiety. Royal Philips announced a global collaboration with The Walt Disney Company to integrate Disney’s clinical storytelling capabilities and animated characters into pediatric MRI environments through Philips Ambient Experience systems. The initiative introduces immersive visual projections, synchronized audio environments, and customized applications such as Pediatric Coaching and Scan Buddy to create a more engaging imaging experience for children.
This innovative approach addresses one of the most persistent challenges in pediatric diagnostic imaging: patient movement during scans. By creating calming and interactive MRI environments, healthcare providers can reduce anxiety, improve scan compliance, and lower the need for pharmacological sedation. The increasing adoption of patient-centered imaging solutions, pediatric MRI technologies, immersive healthcare environments, and anxiety-reduction imaging systems reflects a broader industry commitment to enhancing patient outcomes while improving imaging workflow efficiency.

AI-Powered Spectral CT Systems Advancing Precision Diagnostics

Artificial intelligence is becoming a central driver of innovation within the diagnostic imaging market. Royal Philips achieved a significant milestone with U.S. FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral computed tomography (CT) system. The advanced imaging platform integrates native artificial intelligence algorithms directly into the detector workflow, enabling simultaneous acquisition of high-definition spectral and conventional CT data during every examination.
Unlike traditional imaging approaches that often require specialized protocols to obtain spectral information, Verida captures comprehensive diagnostic data without increasing radiation exposure or modifying routine scanning procedures. The system is specifically designed to enhance tissue characterization and improve diagnostic confidence in complex oncology and cardiovascular imaging applications. The growing adoption of AI-powered CT scanners, spectral CT imaging, advanced diagnostic imaging systems, oncology imaging technologies, and cardiovascular imaging platforms is strengthening the role of precision diagnostics across healthcare institutions.

Cloud-Based Enterprise Imaging Platforms Transforming Clinical Workflows

Another key trend driving the diagnostic imaging industry is the transition toward cloud-native enterprise imaging ecosystems that unify multiple imaging modalities and artificial intelligence applications within a single workflow environment. DeepHealth, a wholly owned subsidiary of RadNet, introduced its cloud-first enterprise imaging portfolio at the European Congress of Radiology (ECR 2026). The platform integrates dedicated AI modules for magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound, and mammography into a centralized diagnostic imaging workspace.
The enterprise architecture includes the newly CE-marked TechLive™ remote image engine, which supports advanced imaging operations and workflow optimization across distributed healthcare networks. Additionally, the platform incorporates a breast arterial calcification (BAC) algorithm capable of extracting cardiovascular risk insights directly from routine mammography examinations. This capability demonstrates how artificial intelligence is expanding the clinical value of diagnostic imaging beyond its original purpose, enabling opportunistic screening and broader population health management.
The increasing deployment of enterprise imaging software, cloud-based radiology platforms, AI-powered diagnostic workflows, remote imaging technologies, and multimodality imaging solutions is helping healthcare organizations improve efficiency, enhance collaboration, and maximize the clinical utility of imaging data. As artificial intelligence, spectral imaging, cloud infrastructure, and patient-focused imaging innovations continue to advance, the diagnostic imaging industry is evolving into a highly integrated ecosystem that supports faster diagnosis, improved clinical decision-making, and more personalized healthcare delivery.

Diagnostic Imaging Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Diagnostic Imaging market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Hologic, Inc., Shimadzu Corporation, Samsung Healthcare, Esaote S.p.A., Carestream Health. The Diagnostic Imaging market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Diagnostic Imaging industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Diagnostic Imaging Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Diagnostic Imaging companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Diagnostic Imaging markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Diagnostic Imaging Market Competitive Benchmarking and Company Analysis

Leading companies in Diagnostic Imaging industry include- Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Hologic, Inc., Shimadzu Corporation, Samsung Healthcare, Esaote S.p.A., Carestream Health. The Diagnostic Imaging market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Diagnostic Imaging Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Diagnostic Imaging market remains one of the strongest-performing segments in the country.
The US Diagnostic Imaging Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Diagnostic Imaging market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Diagnostic Imaging industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Diagnostic Imaging markets

Canada's strong Diagnostic Imaging sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Diagnostic Imaging market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Diagnostic Imaging Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Diagnostic Imaging market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Diagnostic Imaging population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Diagnostic Imaging industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Diagnostic Imaging market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Diagnostic Imaging sales through 2034

France Diagnostic Imaging companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Diagnostic Imaging Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Diagnostic Imaging distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Diagnostic Imaging Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Diagnostic Imaging market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Diagnostic Imaging industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Diagnostic Imaging industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Diagnostic Imaging Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Diagnostic Imaging market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Diagnostic Imaging market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Diagnostic Imaging Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Diagnostic Imaging Market Segmentation

By Modality:
X-Ray Systems
Computed Tomography
Magnetic Resonance Imaging
Ultrasound Systems
Nuclear Imaging
Mammography Systems
Fluoroscopy Systems
By Application:
Cardiovascular
Oncology
Neurology
Musculoskeletal
Gastroenterology
Obstetrics
By End-User:
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Academic & Research Institutes
Physician Offices & Outpatient Clinics

Top Companies in Diagnostic Imaging Industry

Siemens Healthineers AG
GE HealthCare Technologies Inc.
Koninklijke Philips N.V.
Canon Medical Systems Corporation
Fujifilm Holdings Corporation
Hologic, Inc.
Shimadzu Corporation
Samsung Healthcare
Esaote S.p.A.
Carestream Health

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025